IMMUNOHISTOCHEMISTRY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

The global immunohistochemistry market is estimated to be valued at USD 3.07 Bn in 2025 and is expected to exhibit a CAGR of 6.7% during the forecast period (2025-2032). Immunohistochemistry (IHC) is a technique used to detect antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. IHC enables researchers to identify cell types and locations of biomarkers as well as the distribution of target antigens in normal and diseased tissues. It helps in disease diagnosis, prognostic evaluation, and predictive and personalized medicine. IHC uses affinity between antibodies and antigens for making specific proteins in cells of a tissue sample visible microscopically, thus aiding in the identification of cell type and localization of biomolecules. The cells, antigens, and antibodies used must be carefully controlled to ensure accurate and reproducible results.

Market Dynamics

The global immunohistochemistry market is primarily driven by the rising geriatric population and associated increase in prevalence of chronic and infectious diseases. According to the World Health Organization (WHO) October 2022 report, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. The growing incidence of cancer worldwide is also boosting the demand for IHC assays to detect biomarkers related to cancer diagnosis and prognosis. However, stringent regulatory frameworks for the approval of IHC diagnostic kits and lack of skilled personnel especially in developing nations are some challenges restraining the market growth. The emergence of digital pathology solutions offering automated quantification of IHC staining and integration of Artificial Intelligence for more accurate analysis present lucrative opportunities for market players.

Key Features of the Study

• This report provides an in-depth analysis of the global immunohistochemistry market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global immunohistochemistry market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Merck KGaA, Rockland Immunochemicals Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB, Agilent Technologies Inc., Abcam plc., Becton Dickinson and Company, Miltenyi Biotec, Biocare Medical LLC, Eagle Biosciences Inc., Bio-Techne, Diagnostic Biosystems Inc., and BioGenex.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global immunohistochemistry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunohistochemistry market.

Market Segmentation

• Product Insights (Revenue, USD Bn, 2020 - 2032)
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Reagents
    • Proteolytic Enzymes
    • Fixation Reagents
    • Histological Stains
    • Diluents
    • Others
  • Equipment
    • Slide-staining systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
  • Kits
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Neurological Diseases
    • Others Diseases
  • Research
  • Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Diagnostics Laboratories
  • Academic & Research Institutes
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Merck KGaA
  • Rockland Immunochemicals Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • Bio SB
  • Agilent Technologies Inc.
  • Abcam plc.
  • Becton Dickinson and Company
  • Miltenyi Biotec
  • Biocare Medical LLC
  • Eagle Biosciences Inc.
  • Bio-Techne
  • Diagnostic Biosystems Inc.
  • BioGenex.